First and second-line therapy of high-risk MDS patients

被引：0
|
作者：
Platzbecker, U. [1 ]
机构：
[1] Uniklin Dresden, Med Klin 1, Dresden, Germany
来源：
ONKOLOGIE | 2013年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：22 / 22
页数：1
相关论文
共 50 条
  • [1] Second-line treatment in MDS
    Platzbecker, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 149 - 149
  • [2] First-line and second-line antiretroviral therapy
    Calmy, A
    Pascual, F
    Ford, N
    LANCET, 2004, 364 (9431): : 329 - 329
  • [3] Second-Line Therapy for Patients With Hepatocellular Carcinoma
    Frenette, Catherine T.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (12) : 3 - 5
  • [4] Second-line cannabis therapy in patients with epilepsy
    Braun, Erica
    Gualano, Francesca M.
    Siddarth, Prabha
    Segal, Eric
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2023, 227
  • [5] Second-Line Therapy for Patients With Chronic Myeloid Leukemia Resistant to First-Line Imatinib
    Lau, Anna
    Seiter, Karen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 186 - 196
  • [6] Association of First-Line and Second-Line Antiretroviral Therapy Adherence
    Ramadhani, Habib O.
    Thielman, John A. Bartlett Nathan M.
    Pence, BrianW.
    Kimani, Stephen M.
    Maro, Venance P.
    Mwako, Mtumwa S.
    Masaki, Lazaro J.
    Mmbando, Calvin E.
    Minja, Mary G.
    Lirhunde, Eileen S.
    Miller, William C.
    OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (02):
  • [7] First-line therapy for "high-risk prostate cancer"
    Rexer, H.
    UROLOGE, 2014, 53 (07): : 1063 - 1064
  • [8] Should thiazide diuretics be first-line therapy for high-risk hypertensive patients?
    Kohli, S
    Joneja, A
    CANADIAN FAMILY PHYSICIAN, 2004, 50 : 713 - 715
  • [9] Combination therapy is preferred for the first-line treatment of hypertension in high-risk patients
    Drugs & Therapy Perspectives, 2010, 26 (7) : 17 - 20
  • [10] SECOND-LINE THERAPY ON CANCER OF UNKNOWN PRIMARY IN UNFAVORABLE-RISK PATIENTS
    Shimoi, T.
    Sasak, E.
    Okamoto, R.
    Maeda, Y.
    Sasaki, T.
    ANNALS OF ONCOLOGY, 2012, 23 : 164 - 164
12345